Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Rectal Neoplasms × Melphalan × Clear all

Phase

Status

Completed 6 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 14 Myelodysplastic Syndromes 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Multiple Myeloma 8 Hematologic Neoplasms 6 Neuroblastoma 4 Myeloproliferative Disorders 4 Hodgkin Disease 4 Retinoblastoma 3 Lymphoma, Non-Hodgkin 3 Leukemia, Myelomonocytic, Chronic 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Graft vs Host Disease 3 Anemia, Refractory, with Excess of Blasts 3 Recurrence 2 Primary Myelofibrosis 2 Myelodysplastic-Myeloproliferative Diseases 2 Lymphoma 2 Leukemia, Biphenotypic, Acute 2 Leukemia, B-Cell 2 Leukemia 2 Anemia, Aplastic 2 beta-Thalassemia 1 Venentoclax 1 Thrombocythemia, Essential 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Rectal Neoplasms 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1

Interventions

Capecitabine 25 Oxaliplatin 23 Radiotherapy 16 Fluorouracil 15 Surgical Procedures, Operative 11 Drug Therapy 10 Chemoradiotherapy 9 Bevacizumab 9 Leucovorin 8 Consolidation Chemotherapy 7 Radiation 6 sintilimab 5 XELOX 5 Specimen Handling 5 Irinotecan 5 Folfox protocol 5 spartalizumab 4 Radiotherapy, Intensity-Modulated 4 Neoadjuvant Therapy 4 Cetuximab 4 trifluridine tipiracil drug combination 3 pembrolizumab 3 irinotecan sucrosofate 3 fludarabine 3 dehydroftorafur 3 Proctectomy 3 Nivolumab 3 Mastectomy, Segmental 3 Magnetic Resonance Spectroscopy 3 Endoscopy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06607458 2026-03-13

DEL-LIVER

Delcath Systems Inc.

Phase 2 Recruiting

Gastrointestinal

Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡